Q2 2017 Holdings
Filed 2017-08-14 | 67 holdings | $9.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.9M | 49,095 | 39.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.6M | 5,777 | 15.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.5M | 16,762 | 15.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.5M | 29,482 | 15.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $734.0K | 133,500 | 7.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $302.0K | 21,009 | 3.0% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $259.0K | 2,562 | 2.6% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $7.0K | 130,500 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.4K | 83,700 | 0.1% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $5.0K | 65,000 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $5.0K | 65,000 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.0K | 90,000 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $4.3K | 35,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.1K | 120,000 | 0.0% |
| Ishares TR(IBB)Put | NASDQ BIOTEC ETF | 464287556 | $3.9K | 12,500 | 0.0% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $3.9K | 12,500 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.8K | 112,300 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.6K | 60,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $2.5K | 45,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.5K | 42,623 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.4K | 18,994 | 0.0% |
| Proshares TR(BIB)Put | PSHS ULT NASB | 74347R214 | $2.3K | 42,500 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.2K | 17,832 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $2.2K | 43,867 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.2K | 4,532 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.1K | 3,594 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $1.9K | 56,796 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.9K | 97,199 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $1.9K | 14,344 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $1.8K | 35,093 | 0.0% |
| Ignyta Inc | COM | 451731103 | $1.8K | 170,500 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $1.7K | 9,915 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $1.7K | 9,821 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.4K | 15,000 | 0.0% |
| Lilly ELI & Co(LLY)Call | COM | 532457108 | $1.2K | 15,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $1.2K | 25,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $1.2K | 9,526 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $1.1K | 13,800 | 0.0% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $1.0K | 16,002 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $964 | 40,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $905 | 100,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $706 | 10,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $699 | 5,000 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $613 | 5,915 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $537 | 17,970 | 0.0% |
| Medicines Co | COM | 584688105 | $532 | 14,000 | 0.0% |
| Checkpoint Therapeutics Inc(CKPTUSD)A | COM | 162828107 | $530 | 117,760 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $527 | 20,414 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $525 | 30,000 | 0.0% |
| Intrexon Corp | COM | 46122T102 | $442 | 18,345 | 0.0% |